Quest will become the exclusive independent national laboratory provider of clinical lab and anatomic pathology services for Sentara members in Florida and Virginia.

Last week, readers were most interested in a story about how diagnostic firms may be impacted by the FDA's final rule on laboratory-developed tests.

Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how ...

In particular, new FDA requirements around modifying IVDs could lead labs to push for IVD vendors to validate their tests ...

The UCLA-led research team used synthetic peptides and a machine learning-developed algorithm to create a test for the ...

Stratipath Breast risk stratifies breast cancer by analyzing digitized histopathology slides of breast cancer tissue.

The firm will use the money to help advance the development of its digital slide image sharing platform, invest in personnel, and reach regulatory milestones.

The company said the parties had not met certain milestones required for commercialization of the test, which predicts risk of diabetic kidney disease.

Rome-based Policlinico Gemelli will establish an in-house liquid biopsy testing service within its hospital system utilizing Guardant360 CDx.

The machine learning framework extracts features from digital pathology slides to diagnose and predict multiple types of cancer.

The firm said that it plans to use the money to help launch its diagnostics division, expand its testing menu, and hire a chief operating officer.

GenomOncology's Pathology Workbench will be used as the clinical genomic reporting platform for Precipio's myeloid neoplasm test.